Cancer-Focused Firm Leads 4 IPO Launches Totaling $353M
Four companies launched plans Monday for initial public offerings that could raise a combined $353 million in the coming days, led by a Gibson Dunn-advised biotechnology firm that expects to net...To view the full article, register now.
Already a subscriber? Click here to view full article